FDA Says Not Enough Evidence to Drop Chantix Warning
Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior. The twice-a-day tablet has carried the Food and Drug Administration’s strongest warning label, known as …